Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk's liquid Norditropin now available in U.S.

Oct. 5, 2000

Novel GH secretagogues emerge from Japanese/U.S. R&D collaboration

Oct. 4, 2000

Takeda describes compounds which enhance bone formation

Oct. 4, 2000

Novel polypeptide with potential for diabetes Rx described by ZymoGenetics

Oct. 3, 2000

FDA approves Fosamax for use in men with osteoporosis

Oct. 3, 2000

First approval for recombinant drug for infertility

Oct. 3, 2000

Ligand's lasofoxifene enters phase III for osteoporosis, triggering milestone payment

Oct. 2, 2000

Taiho describes new series for use in reducing elevated ammonia levels

Oct. 2, 2000

New vitamin D compounds for bone disorders prepared at Sumitomo

Oct. 2, 2000

Meiosis-regulating cholestane compounds designed by Schering

Oct. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...